My Best Ideas 13 August 2017 This is a list of companies that have a very nice estimated one year return on invested capital based on the sum of the delta of the one year estimated price target plus the calculated one year dividend yield. (Full List)
Dividend Increases 14 - 18 August 2017 This is a list of those companies that have recently increased their dividends. The list includes the amount and percentage of the increase, the forward dividend yield, and the ExDividend, Record and Payment dates. (Full List)
A Tale of Two Charts 13 August 2017 Last week's falling markets were in contrast to the previous weeks and months of the indexes moving higher and has sent doubt through through the minds of a lot of investors. Everyone knows the markets are expensive. But they've been that way for quite a while. That in itself doesn't mean they're about to fall. A quick look at the two charts to the left and investors/traders can come up with two distinct interpretations. The DJIA has been bouncing off it's 20 dma and we could simply be seeing another bounce off that average. The SPX, however, looks a little more serious as it's pushed through both the lower Bollinger Band and a level of support at 2453. This week we'll find out which one is predicting the market's path forward. With earnings having been strong this quarter, I expect this pullback to be temporary and the indexes to return to new highs very soon. In fact, I think the DJIA finding 23,000 this year is a distinct possibility. At least I have my fingers crossed.
Monday Close: The markets opened strong but leveled out shortly after the opening. Apparently the latest crisis with North Korea isn't as much of a crisis as originally thought. Oil also settled slightly lower which is always good for the economy. The DJIA has a nice bounce off its 20 dma. Tuesday Close: A tough day for investors and a great day for day traders. The market opened up and almost immediately started to fall. By 2pm it was pretty much down for the day when suddenly it moved higher. Then in the last ten minutes everything fell back to about where it closed yesterday. All in all, it was much to do about nothing. Wednesday Close: The indexes had a great start and moved higher throughout the morning but couldn't hold the gains in the afternoon as the DJIA finished the day up just 25 points. The SPX and NASDAQ had similar gains. It appears that the 20 dma continues to provide support for this upward trend. Thursday Close: Today opened lower and then continued to fall throughout the day and ending the day with the biggest loss in months with he DJIA down 274 points. Today established a lower low and forcing a lower high on very high volume. Short term weak support won't surface until it falls another 120 points.
Acadia Pharmaceuticals 17 August 2017 ACADIA Pharmaceuticals is focused on the development and commercialization of innovative medicines to address unmet medical needs in neurological and related central nervous system disorders. Their efforts are focused in Parkinson’s disease psychosis, for which they have the first and only treatment approved by the FDA, as well as clinical... (Full Article)
Vericel Corporation 16 August 2017 Vehicle Corp is a commercial stage company with three marketed drugs. The company's research focus is on cell based therapies. In the spring of 2013 Vericel acquired from Sanofi their "cell therapy and regenerative medicine business" which it had received when it purchased Genzyme in 2011. (Full Article)
Advanced Energy Industries 15 August 2017 Advanced Energy Industries is an American company that develops power and control technologies for the manufacture of flat panel displays, semiconductors, data storage products, solar cells and architectural glass. Founded in 1981, AE operates in regional centers in North America, Asia, and Europe. (Full Article)
Corindus Vascular Robotics 10 August 2017 Corindus Vascular Robotics is in the robotic-assisted precision vascular intervention systems industry. They design, manufacture, and sell robotic systems for use in interventional vascular procedures. Corindus came to my attention during one of my screens because of its change in trend earlier this year. This signaled for me a significant and sustainable move higher. My conclusion is to start a small position and see where it goes. (Full Article)
HealthEquity 8 August 2017 Health Savings Accounts may just be the solution to this country's current healthcare crisis and HealthEquity Inc may just be the company with that solution. HealthEquity Inc is a non-bank health savings trustee which allows HealthEquity to be the custodian of health savings accounts regardless of which financial institution the funds are deposited with. (Full Article)
Vertex Pharmaceuticals 3 August 2017 Vertex is an American pharmaceutical company founded in 1989 and located in Boston, Massachusetts. The Company was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. Its product pipeline focused on viral infections, inflammatory and autoimmune disorders, and cancer. (Full Articles)
Who's Reading All These Articles? 2 August 2017 Thanks to everyone who has visited this website lately. Investors and traders now read these article more than 200,000 times each month. I'm amazed and humbled. I hope everyone of those readers initiates a website of their own. It's the kind of thing that forces investors to clarify their strategies and tactics for investing. It also improves their bottom line. I wish everyone the best in all their trades.
Four Years Later and Still No Ads 1 August 2017 Four years ago I had this little idea of creating a website for the purpose of sorting out all my ideas about investing. Writing everything down on scraps of paper and then trying to learn from my mistakes wasn't working. I kept losing my notes and then making the same mistakes over and over again. I had to find a better way. (Full Article)
BioSpecifics Technologies Corp 25 July 2017 BioSpecifics is a biopharmaceutical company that has developed injectable collagenase for 12 clinical indications to date. Injectable collagenase is marketed as XIAFLEX® in the U.S. for the treatment of Dupuytren's contracture and Peyronie's disease by BioSpecifics' partner, Endo. XIAFLEX® is also commercialized in Japan, Europe, Canada and Australia for Dupuytren’s contracture and also for Peyronie's disease in Europe and Australia. (Full Article)
Facebook 24 July 2017 It's hard to find a stronger chart than Facebook's chart and everyone knows the company's story. They've even made a movie of it. But even at $165 per share the projected price target of at least $200 provides for a very nice 21% return. That's not something I'm about to walk away from.
Visa and MasterCard 23 July 2017 No explanation is needed to understand a debit and credit card company. We all carry them with us wherever we go. They are now integral to the modern lifestyle. And everyone knows that they're making tons of money. Just look at your recent credit card statement. But they're not cheap. They never were. But at the end of the day they've made a lot of money for their shareholders.
Interesting Charts 18 July 2017 This is a few ideas I looking at for this week. I've become interested simply based on their charts alone. I'll do more research before I trade the long ideas but I'm already positioned to benefit from a fall in the shares of SNAP. So despite my aversion to trading the perils of an American company, I think the money's to be made on the short side. (Full Article)
An Update on RICK's 14 July 2017 RCI Hospitality has been beefing up it's collection of Gentlemen's Clubs while at the same time continuing to develop its entry into the Casual Dining segment of the restaurant business. And so far its starting to gain traction as plans to expand move forward. But this is a transition period that's setting the groundwork for increasing revenues, earnings and dividends.(Full Article)
TTM Technologies 11 July 2017 TTM Technologies, Inc. is one of the world's largest printed circuit board (PCB) manufacturers, focusing on quickturn and technologically advanced PCB, backplane assemblies and electro-mechanical solutions. TTM provides time-to-market and advanced technology products and offers a one-stop manufacturing solution to customers from engineering design to prototype development through final volume production. (Full Article)
Take-Two Interactive 6 July 2017 Take-Two Interactive is a creator and distributor of video games and peripherals and owns Rockstar Games and 2K Games. Notable game series include Grand Theft Auto, Civilization, NBA 2K, BioShock and Borderlands. As owner of 2K Games, Take-Two publishes its 2K Sports titles, and creates free-to-play mobile titles through Social Point. (Full Article)
Weight Watchers 3 July 2017 There's no doubt that the world is getting bigger. Luckily Weight Watchers has been assisting individuals in their attempt to loose weight for quite a few years. Now the stock has started to get traction, has moved above resistance and has started to move higher. That may be the result of a turnaround currently going on as the fundamentals have significantly improved lately. (Full Article)
The Walt Disney Company 26 June 2017 The Disney chart is showing support in the low $90s and resistance near $120. As a result, this is shaping up to be a great swing trade. But at $104, however, it's just not ready to be traded yet. I'll be looking for a drop of about another $10.
Omeros Corporation Snapshot 23 June 2017 Omeros Corporation discovers and develops small-molecule and protein therapeutics, and orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company markets OMIDRIA for use during cataract surgery or intraocular lens replacement. Its clinical programs include treatment of atypical hemolytic uremic syndrome, thrombotic microangiopathies, IgA nephropathy, and other renal diseases, Huntington's diseases and schizophrenia, opioid and nicotine addiction, urological procedures and much, much more. Omeros Corporation was incorporated in 1994 and is based in Seattle, Washington.
Omeros Corp Daily Chart
TransAct Technologies 22 June 2017 TransAct is a leader in printers, terminals, software and other products for transaction-based industries. These industries include casino and gaming, lottery, food safety, banking, point-of-sale, hospitality, oil and gas, and medical and mobile. TransAct printers and products are designed from the ground up based on market-specific requirements. (Full Article)
Novocure 20 June 2017 Novocure may have finally found a bottom earlier this year. The stock has doubled since April and it's starting to look like there's a lot more room to go even higher. The Company has developed a 4th method of treating cancers that can augment or replace surgery, radiation therapy and chemotherapy. (Full Article)
Dividend, Growth, Low Debt 15 June 2017 The following is a list of 98 stocks that meet the following requirements: Dividend yield of at least 1%, an expected price target 10% higher than today's price, a debt level less than equity, a forward P/E under 25, and a PEG under 2. The list is rank ordered by earnings per share growth over the next 5 years. (Full Article)
Immunomedics 13 June 2017 This Company caught my attention after just one look at the P&F chart. For 7 years there's been resistance near $7 per share as the stock was turned back three times before breaking through. It's now pushed above $8 per share. I believe shares of this company will find support near $7 per share if there's any pullback in the shares and they'll rise to near $12 per share over the next year as earnings turn positive. (Full Article)
Legg Mason - A Purely Technical Call 12 June 2017 LM has just pushed through resistance near $38.60 and now has the potential to move up to near $55 per share with little resistance. Earnings next year are expected to be $3.21 and the long term earnings growth is expected to be 17.10%. This is too good to pass up.
Evolent Health 5 June 2017 Evolent Health provides healthcare delivery and payment solutions. The Company supports integrated health systems in migration toward value-based care and population health management and provides customers with a population management platform, integrated data and analytics capabilities, pharmacy benefit management services, and comprehensive health plan administration services. I'm highlighting this company because a move above 26 tomorrow will signal a breakout above resistance.
Extreme Networks 2 June 2017 Extreme Networks provides software-driven networking solutions for enterprise customers worldwide. The company designs, develops, and manufactures wired and wireless network infrastructure equipment, and develops the software for network management, policy, analytics, security, and access controls. I'm highlighting this company because I initiated a buy-write strategy today for a quick 5% return over a two week period. It can be an effective short term strategy.
Allied Motion Technologies 1 June 2017 Allied Motion Technologies produces precision and specialty motion control components and systems for commercial, industrial, aerospace and defense markets. The company provides motion control products and systems as solutions for a range of applications in aerospace and defense, medical, vehicle, commercial, and industrial. (Full Article)
Always Have an Exit Strategy The exit strategy is always a mandatory precondition for any trade I enter. All other strategies will have disaster embedded at their core. All other strategies are simply an emotional reaction to events external to the markets. All other strategies will accentuate a reward while ignoring the damage that's incurred by accepting such an extensive implied risk. These are the strategies that I personally refuse to implement into my trading strategy. (Full Article)
The Spoils of Investing Sometimes it's good to take money out of the market and enjoy the spoils of investing. Not everything needs to be continually reinvested back into the markets. Three years ago I decided to spoil my son. So I got him this Nissan 370Z. It's been a great car. He's been a great kid!
Interested in reading more articles like the ones above? I've been writing articles for over three years and many of my best ideas can be found in those articles. Click the button below or use the drop down menu above labeled "INDEX". Reflection is often the first step in finding success in the markets.
Investors and Traders Read These Articles As Many As 200,000 Times Each Month.
In 2016 the DJIA ended at 19,762
In 2015 the DJIA ended at 17,425
In 2014 the DJIA ended at 17,823
In 2013 the DJIA ended at 16,576
One Percent per Month
My Investing Strategy I like to keep things simple when I invest because I'm a pretty simple guy. And I don't think there's a simpler or an easier way to invest than "Buy, Write, Collect". Here's the three steps in their entirety. 1. Buy the Stock, 2. Write the Option, and 3. Collect the Dividend. (Full Article)
A Basic Options Strategy If you’ve ever considered an options strategy as part of your overall investment strategy, here’s a relatively simple trade that I often execute to supplement my dividend income. (Full Article)
Reviewing Those Dividend Increases I've listed companies increasing their dividend in the Dividend Increases part of this site because I've found this to be a fertile area for finding candidates for consideration. Companies that pay an annual dividend of at least 2% and increase that dividend at a rate greater than inflation for a number of years are the kind of companies that every DGI is attracted to. And if that company has a one year estimated capital gain of 10% or more, I start to buy shares in that company.
Buying Great Companies I've posted a lot of great companies that have raised their dividend pretty consistently over the years and that's the key to becoming a successful investor. It's really not as hard as most people think. Study those companies that raise their revenues, earnings and dividends over an extended period of time. Read their history. And learn what makes a great investment.
DISCLAIMER I am not a licensed investment adviser, and I am not providing investment advice for you on this site. Please consult with an investment professional before you invest your money. Any opinion expressed here should not be treated as investment advice. I am not liable for any losses suffered by any party because of data or information published on this blog. Past performance is not a guarantee of future performance. Unless your investments are FDIC insured, they may decline in value.